See every side of every news story
Get Started
SubscribeLogin
Basketball
Donald Trump
CPAC
Everton
Pope Francis
Hamas
Ukraine War
Volodymyr Zelenskyy
Baseball
Elon Musk
Israel-Hamas Conflict
Premier League
Published • loading... • Updated

JONS and Tigerlily Foundation Partner on National Health Equity Initiative to Accelerate Breast Cancer Advocacy

Summary by kalkinemedia.com
Amplity's premier journal JONS and the Tigerlily Foundation have partnered to advance health equity initiatives for breast cancer training and clinical trials. LANGHORNE, PA, UNITED STATES, January 16, 2025 /EINPresswire.com/ -- JONS and Tigerlily Foundation Partner on Groundbreaking National Health Equity Initiative to Accelerate Breast Cancer Advocacy, Education, and Empowerment The Journal of Oncology Navigation & Survivorship (JONS), Amplity…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
kalkinemedia.comkalkinemedia.com

JONS and Tigerlily Foundation Partner on National Health Equity Initiative to Accelerate Breast Cancer Advocacy

Amplity's premier journal JONS and the Tigerlily Foundation have partnered to advance health equity initiatives for breast cancer training and clinical trials. LANGHORNE, PA, UNITED STATES, January 16, 2025 /EINPresswire.com/ -- JONS and Tigerlily Foundation Partner on Groundbreaking National Health Equity Initiative to Accelerate Breast Cancer Advocacy, Education, and Empowerment The Journal of Oncology Navigation & Survivorship (JONS), Amplity…

Read Full Article
Breast Cancer Research FoundationBreast Cancer Research Foundation

BCRF-Supported Study Clarifies Risk Potential for 7,000 BRCA2 Variants | Breast Cancer Research Foundation

Practice-changing findings may improve risk assessment and personalize treatments for patientsA major BCRF-supported study published this week in Nature is poised to change genetic testing, risk assessment, and personalized treatment for patients with BRCA2 mutations.Researchers used CRISPR/Cas9 targeting to analyze an astounding 7,000 BRCA2 variants of uncertain significance (VUS) to determine which variants increased cancer risk and which did …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Breast Cancer Research Foundation broke the news in on Wednesday, January 15, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Nature

Nature

Langhorne

Langhorne

News
For You
Search
BlindspotLocal